Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Nov;65(11):4801–4805. doi: 10.1128/iai.65.11.4801-4805.1997

Serum antibodies to Porphyromonas gingivalis block the prostaglandin E2 response to lipopolysaccharide by mononuclear cells.

B W Bainbridge 1, R C Page 1, R P Darveau 1
PMCID: PMC175689  PMID: 9353068

Abstract

The ability of rabbit and monkey immune sera to neutralize prostaglandin E2 (PGE2) production by human monocytes stimulated with lipopolysaccharide (LPS) was examined. CD14-dependent LPS activation of PGE2 was examined under assay conditions which allowed the comparison of preimmune and immune sera. Serum obtained from rabbits immunized with formalin-fixed Porphyromonas gingivalis cells dramatically reduced the amount of PGE2 produced in response to LPS obtained from three different strains of P. gingivalis but not that from Escherichia coli or Bacteroides fragilis. In addition, a significant reduction in the mean PGE2 level was observed in the presence of sera from immunized but not control monkeys employed in a vaccine trial. Immune serum samples from five of nine immunized monkeys were able to reduce LPS-induced production of PGE2 by greater than 50% compared to that in the corresponding preimmune sera. Immune monkey serum, similar to immune rabbit serum, blocked PGE2 production in response to P. gingivalis LPS but not E. coli LPS. These data demonstrate that immunization with P. gingivalis whole cells can elicit an antibody response that is able to block the PGE2 response to LPS. Neutralization of LPS-mediated inflammatory mediator production may account in part for the observed suppression of alveolar bone loss in immunized monkeys.

Full Text

The Full Text of this article is available as a PDF (640.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. M., Ebersole J. L., Novak M. J. Functional properties of nonhuman primate antibody to Porphyromonas gingivalis. Infect Immun. 1995 Sep;63(9):3245–3252. doi: 10.1128/iai.63.9.3245-3252.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen H. A., Johnson B. D., Sims T. J., Darveau R. P., Moncla B. J., Whitney C. W., Engel D., Page R. C. Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients. J Periodontol. 1991 Dec;62(12):781–791. doi: 10.1902/jop.1991.62.12.781. [DOI] [PubMed] [Google Scholar]
  3. Cutler C. W., Kalmar J. R., Arnold R. R. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun. 1991 Jun;59(6):2097–2104. doi: 10.1128/iai.59.6.2097-2104.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Darveau R. P., Cunningham M. D., Bailey T., Seachord C., Ratcliffe K., Bainbridge B., Dietsch M., Page R. C., Aruffo A. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun. 1995 Apr;63(4):1311–1317. doi: 10.1128/iai.63.4.1311-1317.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Darveau R. P., Hancock R. E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol. 1983 Aug;155(2):831–838. doi: 10.1128/jb.155.2.831-838.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ebersole J. L., Brunsvold M., Steffensen B., Wood R., Holt S. C. Effects of immunization with Porphyromonas gingivalis and Prevotella intermedia on progression of ligature-induced periodontitis in the nonhuman primate Macaca fascicularis. Infect Immun. 1991 Oct;59(10):3351–3359. doi: 10.1128/iai.59.10.3351-3359.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  8. Genco R. J. Host responses in periodontal diseases: current concepts. J Periodontol. 1992 Apr;63(4 Suppl):338–355. doi: 10.1902/jop.1992.63.4s.338. [DOI] [PubMed] [Google Scholar]
  9. Haffajee A. D., Socransky S. S., Smith C., Dibart S. Relation of baseline microbial parameters to future periodontal attachment loss. J Clin Periodontol. 1991 Nov;18(10):744–750. doi: 10.1111/j.1600-051x.1991.tb00066.x. [DOI] [PubMed] [Google Scholar]
  10. Holt S. C., Brunsvold M., Jones A., Wood R., Ebersole J. L. Cell envelope and cell wall immunization of Macaca fascicularis: effect on the progression of ligature-induced periodontitis. Oral Microbiol Immunol. 1995 Dec;10(6):321–333. doi: 10.1111/j.1399-302x.1995.tb00162.x. [DOI] [PubMed] [Google Scholar]
  11. Jeffcoat M. K., Williams R. C., Reddy M. S., English R., Goldhaber P. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodontal Res. 1988 Nov;23(6):381–385. doi: 10.1111/j.1600-0765.1988.tb01617.x. [DOI] [PubMed] [Google Scholar]
  12. Johne B., Olsen I., Bryn K. Fatty acids and sugars in lipoplysaccharides from Bacteroides intermedius. Bacteroides gingivalis and Bacteroides loescheii. Oral Microbiol Immunol. 1988 Mar;3(1):22–27. doi: 10.1111/j.1399-302x.1988.tb00600.x. [DOI] [PubMed] [Google Scholar]
  13. Meikle M. C., Heath J. K., Reynolds J. J. Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis. J Oral Pathol. 1986 May;15(5):239–250. doi: 10.1111/j.1600-0714.1986.tb00616.x. [DOI] [PubMed] [Google Scholar]
  14. Moore W. E., Moore L. H., Ranney R. R., Smibert R. M., Burmeister J. A., Schenkein H. A. The microflora of periodontal sites showing active destructive progression. J Clin Periodontol. 1991 Nov;18(10):729–739. doi: 10.1111/j.1600-051x.1991.tb00064.x. [DOI] [PubMed] [Google Scholar]
  15. Offenbacher S., Braswell L. D., Loos A. S., Johnson H. G., Hall C. M., McClure H., Orkin J. L., Strobert E. A., Green M. D., Odle B. M. Effects of flurbiprofen on the progression of periodontitis in Macaca mulatta. J Periodontal Res. 1987 Nov;22(6):473–481. doi: 10.1111/j.1600-0765.1987.tb02058.x. [DOI] [PubMed] [Google Scholar]
  16. Offenbacher S., Odle B. M., Van Dyke T. E. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res. 1986 Mar;21(2):101–112. doi: 10.1111/j.1600-0765.1986.tb01443.x. [DOI] [PubMed] [Google Scholar]
  17. Ogawa T. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett. 1993 Oct 11;332(1-2):197–201. doi: 10.1016/0014-5793(93)80512-s. [DOI] [PubMed] [Google Scholar]
  18. Ogawa T. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis. Eur J Biochem. 1994 Feb 1;219(3):737–742. doi: 10.1111/j.1432-1033.1994.tb18552.x. [DOI] [PubMed] [Google Scholar]
  19. Page R. C. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991 May;26(3 Pt 2):230–242. doi: 10.1111/j.1600-0765.1991.tb01649.x. [DOI] [PubMed] [Google Scholar]
  20. Persson G. R., Engel D., Whitney C., Darveau R., Weinberg A., Brunsvold M., Page R. C. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun. 1994 Mar;62(3):1026–1031. doi: 10.1128/iai.62.3.1026-1031.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Peterson A. A., Haug A., McGroarty E. J. Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4. J Bacteriol. 1986 Jan;165(1):116–122. doi: 10.1128/jb.165.1.116-122.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Slots J., Listgarten M. A. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol. 1988 Feb;15(2):85–93. doi: 10.1111/j.1600-051x.1988.tb00999.x. [DOI] [PubMed] [Google Scholar]
  23. Somerville J. E., Jr, Cassiano L., Bainbridge B., Cunningham M. D., Darveau R. P. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest. 1996 Jan 15;97(2):359–365. doi: 10.1172/JCI118423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Van Dyke T. E., Lester M. A., Shapira L. The role of the host response in periodontal disease progression: implications for future treatment strategies. J Periodontol. 1993 Aug;64(8 Suppl):792–806. doi: 10.1902/jop.1993.64.8s.792. [DOI] [PubMed] [Google Scholar]
  25. Vasel D., Sims T. J., Bainbridge B., Houston L., Darveau R., Page R. C. Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus. Oral Microbiol Immunol. 1996 Aug;11(4):226–235. doi: 10.1111/j.1399-302x.1996.tb00174.x. [DOI] [PubMed] [Google Scholar]
  26. Weintraub A., Larsson B. E., Lindberg A. A. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect Immun. 1985 Jul;49(1):197–201. doi: 10.1128/iai.49.1.197-201.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Whitney C., Ant J., Moncla B., Johnson B., Page R. C., Engel D. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun. 1992 Jun;60(6):2194–2200. doi: 10.1128/iai.60.6.2194-2200.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES